Q&A: What Should We Be Doing About the Opioid Crisis?

The opioid crisis has a nasty habit of punishing simple answers. If anyone tells you there is one magic fix, feel free to raise an eyebrow so high it disappears into your hairline. The truth is more complicated, but it is not hopeless. We know a lot more now than we did years ago. We know what saves lives. We know what makes things worse. And we know that the best response is not one big dramatic gesture, but a coordinated set of smart, humane, evidence-based actions.

So, what should we be doing about the opioid crisis? In short: preventing addiction when possible, treating opioid use disorder like the medical condition it is, making naloxone as common as fire extinguishers, reducing harm in the real world, and helping people stay alive long enough to recover. That may not fit neatly on a bumper sticker, but it is a much better plan than crossing our fingers and hoping fentanyl gets bored.

Q&A: The Big Questions We Should Actually Be Asking

Q1: Is the opioid crisis still a crisis if overdose deaths have started to decline?

Yes. A decline is good news, not a victory parade. The United States has seen signs of improvement, but overdose deaths are still heartbreakingly high, and opioids remain a major driver of those deaths. In other words, the fire may be a little smaller, but it is still very much on fire.

This matters because success can make people complacent. Communities may think the problem is solving itself. It is not. Progress is fragile. If lawmakers slash treatment funding, if insurers rebuild old barriers, or if communities stop investing in overdose prevention, the gains can disappear faster than free donuts in a newsroom.

Q2: What is driving the crisis right now?

Today’s opioid crisis is heavily shaped by illegally made fentanyl and a drug supply that has become more unpredictable and more dangerous. Fentanyl shows up in powders, counterfeit pills, and other street drugs, often without the user knowing it. That means many overdoses are not happening because a person intentionally set out to use fentanyl. They happen because the drug market has turned into a chemistry pop quiz nobody agreed to take.

That shift changes how we should respond. It is no longer enough to focus only on prescription misuse. Safe prescribing still matters, absolutely, but the crisis now demands faster overdose response, stronger treatment access, broader public education, and strategies that account for contaminated or counterfeit drugs.

Q3: Should the response start with prevention?

Yes, but prevention has to be smarter than old-school “just say no” messaging. Good prevention means reducing unnecessary opioid exposure, treating pain carefully, educating patients honestly, and identifying risk early. It also means giving people real support before they reach a crisis point.

For clinicians, that includes using nonopioid options first when they are likely to work, especially for many types of acute, subacute, and chronic pain. It also means prescribing the lowest effective dose for the shortest appropriate duration when opioids are necessary, avoiding dangerous combinations when possible, and checking for overdose risk. Good prescribing is not about abandoning pain patients. It is about not turning a short-term pain problem into a long-term disaster.

For families, schools, and community groups, prevention also means honest education. Teens and young adults need to know that a pill bought online or from a friend may not be what it claims to be. In the fentanyl era, “looks legitimate” is not exactly a safety guarantee.

Q4: What should we be doing right now to save lives fast?

Make naloxone everywhere. Not “available somewhere if you ask three people and fill out a form.” Everywhere.

Naloxone reverses opioid overdose and can be given by bystanders. That makes it one of the most practical, immediate tools we have. If a potential bystander is present in a large share of overdose deaths, then the job is obvious: put naloxone into the hands of the people most likely to witness an overdose, and train them to use it without drama or shame.

That means naloxone should be easy to get in pharmacies, schools, libraries, shelters, colleges, community centers, jails, treatment programs, and primary care clinics. It should be part of discharge plans after overdose, part of safer prescribing for higher-risk patients, and part of public health outreach in neighborhoods with high overdose rates.

Think of it this way: we do not argue that only firefighters should have access to fire extinguishers. We should treat naloxone with the same common sense.

Q5: Is naloxone enough?

No. Naloxone is a rescue tool, not a full recovery plan. It buys time, and that time is priceless, but what happens next matters just as much. A person revived from an overdose should not be handed a pamphlet and a polite shrug.

The best systems connect people immediately to care. Emergency departments should be able to start treatment, not just stabilize and discharge. Outreach teams should follow up quickly after nonfatal overdose. Hospitals and first responders should partner with peer recovery specialists who can help people navigate treatment, housing, transportation, insurance, and the terrifying paperwork monster that lives in every health system.

Q6: What treatment should be easier to access?

Medications for opioid use disorder, often called MOUD, should be much easier to start and much easier to stay on. That means methadone, buprenorphine, and naltrexone. These are not “substituting one drug for another,” a phrase that has done more damage than a raccoon in an attic. They are evidence-based treatments that reduce cravings, lower overdose risk, and help people stabilize their lives.

Buprenorphine, in particular, can be offered in primary care, hospitals, community clinics, and other medical settings. Methadone is highly effective too, but access can still be constrained by regulations and geography. Naltrexone can also be useful for some patients. The bigger point is that people should have options, because recovery is not a one-size-fits-all sweater.

If a person is ready for help, the system should not answer with prior authorization, waitlists, complicated intake rules, or “come back next Tuesday between 9:12 and 9:17 a.m.” The response should be: let’s start today.

Q7: Are insurance barriers still part of the problem?

Very much so. Coverage gaps, prior authorization, dosage limits, narrow networks, and inconsistent benefits can delay or block life-saving treatment. Medicaid plays an enormous role in covering people with opioid use disorder, especially those receiving treatment services. That means policy decisions about Medicaid are not abstract budget chess moves. They directly affect whether people can get medication, outpatient care, peer support, and recovery services.

A serious strategy should remove prior authorization for MOUD, improve reimbursement for addiction care, enforce mental health and substance use parity laws, and make it easier for patients to continue treatment rather than constantly prove they still deserve not to die.

Q8: What about harm reduction? Is it helping or just controversial?

It is helping. Harm reduction is controversial mostly because people confuse it with approval. It is not approval. It is triage, realism, and public health. Harm reduction accepts a simple fact: you cannot help a dead person. So the goal is to reduce the risk of overdose, infection, and other harms while also creating doors into treatment and recovery.

That includes distributing naloxone, offering fentanyl education, supporting syringe services programs, and connecting people to testing, vaccination, treatment, and social services. Syringe services programs do more than provide sterile supplies. They reduce the spread of HIV and hepatitis C, create trusted contact points, and link people to substance use treatment and medical care.

If that sounds practical, that is because it is. Public health is often less glamorous than political speeches, but it tends to save more lives.

Q9: Should the response include law enforcement?

Yes, but not as the whole strategy. Law enforcement has a legitimate role in disrupting trafficking networks, addressing counterfeit pills, and responding to large-scale illegal fentanyl distribution. Communities need action against the criminal networks flooding neighborhoods with dangerous drugs.

But enforcement alone is not enough. You cannot arrest your way out of addiction, trauma, untreated pain, homelessness, or a fragmented health care system. A smart response separates two goals that are often blurred together: targeting the illegal supply chain and helping people who are at risk of overdose stay alive and get treatment.

That is the difference between treating people as disposable evidence and treating them as human beings.

Q10: What should hospitals and emergency departments be doing differently?

Hospitals should treat overdose as a medical emergency and a treatment opportunity. That means screening for opioid use disorder, starting buprenorphine when appropriate, providing naloxone at discharge, and arranging rapid follow-up care. A nonfatal overdose is a flashing red warning light. Sending someone home with no medication and no bridge to care is like hearing the fire alarm and deciding the building probably just needs more optimism.

Emergency departments are also ideal places to involve peer support workers. People with lived experience can help patients who may distrust the health system, feel ashamed, or feel too overwhelmed to navigate next steps alone. Their role is not decorative. It can be the difference between a warm handoff and a cold exit.

Q11: What about jails and prisons?

They should offer evidence-based treatment, including MOUD, during incarceration and at reentry. This is one of the clearest opportunities to prevent death. People leaving jail or prison often face a sharply increased overdose risk because their tolerance has dropped and their lives may still be unstable. Cutting them off from treatment at exactly that moment is not tough. It is reckless.

Correctional settings should provide medications, overdose education, reentry planning, naloxone on release, and direct connections to community treatment. This is not only a health issue. It is also a public safety issue. Better treatment after release can reduce reincarceration and improve stability.

Q12: Are peer support and recovery services really that important?

Yes. Treatment is not just about getting someone through withdrawal or prescribing a medication. It is about helping them build a life that does not constantly drag them back toward relapse. Peer support workers, recovery coaches, recovery housing, employment services, transportation assistance, and family support can all strengthen long-term recovery.

People do not recover in a vacuum. They recover in neighborhoods, homes, clinics, support groups, workplaces, and messy daily routines. If someone is trying to stay in treatment but has no safe housing, no phone, no ride, no child care, and no idea how to keep a clinic appointment, the problem is not a lack of willpower. The problem is that the system built a maze and then blamed the person for getting lost.

Q13: What should communities and policymakers do next?

They should stop arguing about whether the answer is prevention, treatment, harm reduction, or recovery support. The answer is yes. All of it. At the same time.

Here is what a serious local and national plan looks like:

• Expand naloxone distribution and public training.
• Make MOUD easy to start in primary care, hospitals, jails, and community clinics.
• Remove insurance barriers, including prior authorization and arbitrary restrictions.
• Support safer prescribing while protecting access to individualized pain care.
• Invest in peer support, recovery housing, and long-term recovery infrastructure.
• Use harm reduction programs to prevent overdose and connect people to care.
• Educate the public about fentanyl and counterfeit pills.
• Improve coordination across health care, public health, schools, social services, and law enforcement.
• Fund what works long enough for it to keep working.

So, What Should We Be Doing About the Opioid Crisis?

We should be responding like adults in a real emergency: with urgency, evidence, compassion, and a long memory for what has already failed. The opioid crisis is not just about drugs. It is about pain, trauma, isolation, policy mistakes, health care access, and a drug supply that has become terrifyingly lethal. The good news is that we already have many of the tools we need.

The challenge is not inventing a miracle. The challenge is doing the obvious, proven things consistently and at scale. Get naloxone into more hands. Get treatment into more settings. Get barriers out of the way. Get people connected to recovery supports that make stability possible. And maybe, just maybe, stop treating compassion like a loophole.

Because the best answer to the opioid crisis is not a slogan. It is a system that makes it easier to survive, easier to get help, and easier to stay well.

Experiences From the Ground: What the Opioid Crisis Looks Like in Real Life

The opioid crisis is often discussed in statistics, policy memos, and grim headlines. Those matter, but they can flatten the human story. The experiences below are written as realistic composite examples based on common patterns described by clinicians, family members, recovery workers, and public health programs. They are not profiles of identifiable individuals, but they reflect what this crisis often looks like on the ground.

A parent’s view: One mother thought the danger was prescription painkillers left in medicine cabinets. Then her son bought what he believed was a legitimate pill from a friend. It was counterfeit and contained fentanyl. The family had no naloxone at home because they did not think of themselves as an “overdose family.” That phrase alone says a lot. Many families still imagine the crisis happens somewhere else, to someone else, under circumstances that look very different from their own kitchen table.

An emergency physician’s view: In many hospitals, overdose patients arrive blue, barely breathing, then wake up scared, sick, and disoriented. The medical team can reverse the overdose, but the larger question arrives two minutes later: what now? The best emergency departments start medication, hand out naloxone, and connect patients with peer support or rapid follow-up. The weaker systems stabilize the patient and discharge them with good wishes. That gap between rescue and treatment can become the whole story.

A rural community’s view: In some small towns, the nearest treatment program may be an hour away. Methadone can require repeated travel. Counseling may be scarce. Public transit may be a fantasy. Broadband may be unreliable. Everyone knows everyone, which sounds charming until stigma enters the room. A person seeking treatment may worry that the pharmacist is their cousin’s neighbor and the clinic receptionist knows their old baseball coach. In those communities, telehealth, local buprenorphine access, mobile services, and peer support are not conveniences. They are lifelines.

A recovery worker’s view: Many people do not fail treatment because they “do not want it badly enough.” They fail because real life is loud. A person may leave detox with no stable housing, no job, no transportation, and no safe place to keep medication. Another may be doing well on buprenorphine until insurance changes, prior authorization delays a refill, and withdrawal pushes everything off a cliff. Recovery workers see this every day: motivation matters, but systems matter too. A lot.

A reentry story: Someone leaves jail after a short stay. Tolerance is down. Stress is high. Housing is uncertain. Old contacts are easy to find; medical care is not. This is one of the most dangerous windows for overdose. Programs that start treatment inside correctional settings and continue it after release can change that trajectory. Without that bridge, release can look less like freedom and more like being dropped onto a tightrope in a windstorm.

A hopeful pattern: Communities do see wins when they build a full response. A school nurse trained to use naloxone. A library that stocks overdose kits. A primary care doctor who starts buprenorphine instead of referring into a three-month waitlist. A sheriff’s office that supports treatment instead of performing a permanent moral lecture. A recovery housing program that allows medication instead of banning it out of ignorance. None of those changes is flashy. Together, they are how a death rate starts to move in the right direction.

The opioid crisis is a public health emergency, but it is also a daily-life emergency. It shows up in bedrooms, break rooms, emergency bays, county jails, foster systems, and family group texts. That is why the response must be practical, not performative. People need tools, treatment, and support where they actually live. And when communities provide those things, the results are not abstract. More people survive. More people stay in care. More families get another chance.